The Myasthenia Gravis Foundation of America requests submission of proposals to support pilot studies that are highly focused and innovative with a clear plan that will lead to new federal, pharmaceutical, or private foundation supported investigations. For additional details, click here.
The Myasthenia Gravis Foundation of America requests submission of proposals to support investigations that are focused, innovative, and highly likely to produce fundamental alterations in the understanding of myasthenia gravis and related disorders. More information to be announced.
To commemorate Dr. John Newsom-Davis’ life and his dedication to improving the treatment of patients with myasthenia gravis, MGFA has established The Dr. John Newsom-Davis Award for Neurology Residents-in-Training (registrars, residents or fellows) to attend scientific or clinical meetings related to myasthenia gravis.
Dr. Newsom-Davis was a leader in clinical and basic research related to myasthenia gravis. His death is a major loss to patients with MG, practitioners and researchers. MGFA is honored to take this step forward towards a “world without MG” by making this new funding available in Dr. Newsom-Davis’ name.
Awards will be given to residents who wish to present their MG related research at a recognized professional event or gathering, such as the MGFA Annual Scientific Session. Other considerations may include travel and lodging for a resident to attend a meeting that might significantly further his or her understanding of MG and related autoimmune diseases.
Applications and selection criteria are available online. All applications are subject to review by members of the MGFA Medical/Scientific Advisory Board with final approval by the MGFA Executive Committee. Donations to the John Newsom-Davis Fund can be made online at click to internal link
Questions may be directed to Nancy Law, chief executive of MGFA, at (800) 541-5454, or by email at email@example.com.